Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: f
View:

• Adult patients ages 18-60

• Spanish or English speaking

• Diagnosis of HTN or BP \>140/90 in last 3 months (based on medical record)

• Hemoglobin A1C\>8 in last 6 months (based on medical record)

• Not pregnant

Locations
United States
Texas
UT Southwestern Medical Center
RECRUITING
Dallas
Contact Information
Primary
Silvia Obregon, MSW
silvia.obregon@utsouthwestern.edu
214-645-9532
Time Frame
Start Date: 2022-07-27
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 100
Treatments
Experimental: Home Visit
Participants will receive home visit During the course of the first home visit, patients will receive routine care for diabetes and hypertension management (outcome variables are listed below) and data will be recorded in the EHR for primary outcomes. The resident physician will also assist the patient in completing enrollment in MyChart (if interested), utilizing either the resident's computer or smartphone and an internet hotspot. MyChart is a patient health platform that allows patients to contact their healthcare doctors, log health reminders, see test results, and a list of medications. The resident physician will also review a social determinants of health (SDH) screener (included in the EHR). The research faculty (licensed medical clinician) will collect blood pressure readings during this visit.
No_intervention: Standard of care
Participants will receive a standard of care
Related Therapeutic Areas
Sponsors
Leads: University of Texas Southwestern Medical Center

This content was sourced from clinicaltrials.gov